Skeletal Health Part 1: Overview Of Bone Health and Management In the Cancer Setting

Urol Nurs. 2016 Jan-Feb;36(1):17-21, 26.

Abstract

Cancer-induced bone disease and cancer therapy-induced bone loss are significant skeletal problems related to the treatment for urological and other cancers. Our team of specialists and nurse practitioners developed a nurse practitioner-led Bone Support Clinic for urologic cancer patients at a university hospital in London, England, United Kingdom, to address this issue. The clinic has been well-accepted, has made a positive impact on the patient journey, helps to ensure continuity of care, and highlights patients who require assessment or treatment for impending skeletal-related events in a timely fashion. This article has been divided into two parts for improved readability.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Bisphosphonate-Associated Osteonecrosis of the Jaw
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Denosumab / therapeutic use
  • Diphosphonates / therapeutic use
  • Fractures, Bone / prevention & control*
  • Humans
  • Neoplasms / complications*
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Osteoporosis / chemically induced
  • Osteoporosis / complications
  • Osteoporosis / drug therapy*
  • Osteoporotic Fractures / prevention & control*

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates
  • Denosumab